Literature DB >> 20544309

The use of single versus dual antiplatelet therapy beyond 1 year following drug-eluting stent implantation.

Matthew E Wiisanen1, David J Moliterno.   

Abstract

Year:  2010        PMID： 20544309     DOI： 10.1007/s11886-010-0128-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  7 in total

1.  Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.

Authors:  Andrew T L Ong; Angela Hoye; Jiro Aoki; Carlos A G van Mieghem; Gaston A Rodriguez Granillo; Karel Sonnenschein; Evelyn Regar; Eugene P McFadden; Georgios Sianos; Willem J van der Giessen; Peter P T de Jaegere; Pim de Feyter; Ron T van Domburg; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

2.  Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.

Authors:  John A Spertus; Richard Kettelkamp; Clifton Vance; Carole Decker; Philip G Jones; John S Rumsfeld; John C Messenger; Sanjaya Khanal; Eric D Peterson; Richard G Bach; Harlan M Krumholz; David J Cohen
Journal:  Circulation       Date:  2006-06-12       Impact factor: 29.690

3.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.

Authors:  Ioannis Iakovou; Thomas Schmidt; Erminio Bonizzoni; Lei Ge; Giuseppe M Sangiorgi; Goran Stankovic; Flavio Airoldi; Alaide Chieffo; Matteo Montorfano; Mauro Carlino; Iassen Michev; Nicola Corvaja; Carlo Briguori; Ulrich Gerckens; Eberhard Grube; Antonio Colombo
Journal:  JAMA       Date:  2005-05-04       Impact factor: 56.272

4.  Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study.

Authors:  Francesco Burzotta; Antonio Parma; Christian Pristipino; Alessandro Manzoli; Flavia Belloni; Gennaro Sardella; Stefano Rigattieri; Alessandro Danesi; Pietro Mazzarotto; Francesco Summaria; Enrico Romagnoli; Francesco Prati; Carlo Trani; Filippo Crea
Journal:  Eur Heart J       Date:  2008-11-05       Impact factor: 29.983

5.  Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.

Authors:  Jochem W van Werkum; Antonius A Heestermans; A Carla Zomer; Johannes C Kelder; Maarten-Jan Suttorp; Benno J Rensing; Jacques J Koolen; B R Guus Brueren; Jan-Henk E Dambrink; Raymond W Hautvast; Freek W Verheugt; Jurriën M ten Berg
Journal:  J Am Coll Cardiol       Date:  2009-04-21       Impact factor: 24.094

6.  Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment.

Authors:  Flavio Airoldi; Antonio Colombo; Nuccia Morici; Azeem Latib; John Cosgrave; Lutz Buellesfeld; Erminio Bonizzoni; Mauro Carlino; Ulrich Gerckens; Cosmo Godino; Gloria Melzi; Iassen Michev; Matteo Montorfano; Giuseppe Massimo Sangiorgi; Asif Qasim; Alaide Chieffo; Carlo Briguori; Eberhard Grube
Journal:  Circulation       Date:  2007-07-30       Impact factor: 29.690

7.  Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents.

Authors:  Duk-Woo Park; Sung-Cheol Yun; Seung-Whan Lee; Young-Hak Kim; Cheol Whan Lee; Myeong-Ki Hong; Sang-Sig Cheong; Jae-Joong Kim; Seong-Wook Park; Seung-Jung Park
Journal:  JACC Cardiovasc Interv       Date:  2008-10       Impact factor: 11.195
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.